Impact of cause of death adjudication on the results of the European prostate cancer screening trial

BACKGROUND: The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduction in prostate cancer mortality at 13 years. The causes of death can be misattributed, particularly in elderly men with multiple comorbidities, and therefore accurate assessment of the underlying c...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Stephen D, de Koning, Harry J, Hugosson, Jonas, Talala, Kirsi, Roobol, Monique J, Carlsson, Sigrid, Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Páez, Álvaro, Moss, Sue, Auvinen, Anssi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220145/
https://www.ncbi.nlm.nih.gov/pubmed/27855442
http://dx.doi.org/10.1038/bjc.2016.378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220145/
https://www.ncbi.nlm.nih.gov/pubmed/27855442
http://dx.doi.org/10.1038/bjc.2016.378

Ejemplares similares